Pharma media agency serving US Rx, OTC, and medical device brands

What a pharma media agency actually does

A pharma media agency sits between a pharmaceutical, OTC or medical device brand and the paid channels — with a compliance layer between them that a general media agency does not carry. The brand hands the agency a promotional intent, an approved label indication and an ISI (Important Safety Information) block. The agency turns that into campaigns that live inside FDA promotional rules, DSCSA constraints on supply-chain claims, and per-audience walls that separate healthcare professional targeting from direct-to-consumer targeting.

The mechanics of paid buying — bid strategies, audience segmentation, creative rotation, frequency management — are broadly the same as any performance agency runs. What is not the same is the artefact library: every branded ad ships with fair-balance, every unbranded disease-awareness campaign is walled off from branded assets, every landing page carries the current ISI, and every ad platform's default optimisation gets overridden where it would otherwise chase clicks into off-label territory.

Ichelon Consulting US operates as the pharma media agency for US Rx brand teams that need a specialist media pod, not a full agency-of-record contract. We plug into the brand's existing MLR workflow, the pharmacovigilance team's AE reporting pipeline, and the brand lead's KPI dashboard — and we deliver from Dallas with pods that work every US time zone.

HCP versus DTC audience targeting

The single hardest part of pharma media is keeping the HCP audience and the DTC audience on separate rails. Every platform's default optimisation wants to blur that line — a lookalike here, an interest overlap there, a broad-audience expansion prompt from the ad platform's own AI recommendation. Ichelon Consulting US's activation team overrides those defaults every time.

HCP targeting layer

NPI-based audience matches through the endemic HCP networks, LinkedIn job-title and industry targeting layered with specialty and years-of-practice signals, and programmatic contextual placements on peer-reviewed publisher inventory. Every HCP creative uses HCP-appropriate language, references the label's indication as it was approved for prescribers, and links to HCP-gated landing pages.

DTC targeting layer

Condition and symptom-intent targeting on Google, Meta and connected TV — with the label's DTC-appropriate language, fair-balance in every unit, and "talk to your doctor" as the primary call to action. Landing pages carry the current ISI, patient-friendly explanations, and a doctor-discussion guide download that carries proper consent for follow-up communication.

Cross-audience firewalls

Retargeting audiences are scoped so an HCP visitor to an HCP-gated page never ends up in a DTC lookalike, and a DTC visitor to a patient page never ends up in an HCP audience seed. This is boring, unglamorous audience-plumbing work — and it is where general media agencies most often trip a compliance review.

Pharma media agency coverage

Ichelon Consulting US's Dallas HQ services US pharma clients nationally. Media is bought on national inventory; MLR coordination runs against the brand's headquarters wherever it sits — Boston, New York, New Jersey pharma corridor, San Francisco Bay biotech cluster, Chicago, Philadelphia and Washington DC included.

Backed by ICG global leadership

Every US pharma media engagement has direct line-of-sight to the Ichelon Consulting Group Leadership Team. Brand teams get a member of the Leadership Team in the room for scoping and quarterly review — the people who scope your engagement are the same people who read the monthly report.

Ichelon Consulting US in the US — other pages